pcDNA3.1-ACE2-GFP Citations (9)
Originally described in: Angiotensin converting enzyme 2 is a novel target of the gamma-secretase complex.Bartolome A, Liang J, Wang P, Ho DD, Pajvani UB Sci Rep. 2021 May 7;11(1):9803. doi: 10.1038/s41598-021-89379-x. PubMed Journal
Articles Citing pcDNA3.1-ACE2-GFP
| Articles |
|---|
| Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai JP, Zhou R, Chan KH, Zhao H, Zhu L, Siu KL, Fung SY, Yung S, Chan TM, To KK, Chan JF, Cai Z, Lau SKP, Chen Z, Jin DY, Woo PCY, Yuen KY. Cell. 2021 Apr 15;184(8):2212-2228.e12. doi: 10.1016/j.cell.2021.02.053. Epub 2021 Mar 2. PubMed |
Angiotensin converting enzyme 2 is a novel target of the gamma-secretase complex.
Bartolome A, Liang J, Wang P, Ho DD, Pajvani UB.
Sci Rep. 2021 May 7;11(1):9803. doi: 10.1038/s41598-021-89379-x.
PubMed
Associated Plasmids |
| An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding. Yip KM, Lee KM, Ng TB, Xu S, Yung KKL, Qu S, Cheung AKL, Sze SCW. Chin Med. 2022 Jul 27;17(1):88. doi: 10.1186/s13020-022-00635-2. PubMed |
| GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. Torrens-Mas M, Perello-Reus CM, Trias-Ferrer N, Ibarguen-Gonzalez L, Crespi C, Galmes-Panades AM, Navas-Enamorado C, Sanchez-Polo A, Pierola-Lopetegui J, Masmiquel L, Crespi LS, Barcelo C, Gonzalez-Freire M. Front Cell Infect Microbiol. 2022 Jul 22;12:942951. doi: 10.3389/fcimb.2022.942951. eCollection 2022. PubMed |
| Autophagy-linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS-CoV-2 entry into human cells. Ugalde AP, Bretones G, Rodriguez D, Quesada V, Llorente F, Fernandez-Delgado R, Jimenez-Clavero MA, Vazquez J, Calvo E, Tamargo-Gomez I, Marino G, Roiz-Valle D, Maeso D, Araujo-Voces M, Espanol Y, Barcelo C, Freije JM, Lopez-Soto A, Lopez-Otin C. EMBO J. 2022 Nov 2;41(21):e110727. doi: 10.15252/embj.2022110727. Epub 2022 Oct 4. PubMed |
| Supported Natural Membranes on Microspheres for Protein-Protein Interaction Studies. Cheppali SK, Dharan R, Katzenelson R, Sorkin R. ACS Appl Mater Interfaces. 2022 Oct 28. doi: 10.1021/acsami.2c13095. PubMed |
| SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly. Onnis A, Andreano E, Cassioli C, Finetti F, Della Bella C, Staufer O, Pantano E, Abbiento V, Marotta G, D'Elios MM, Rappuoli R, Baldari CT. J Exp Med. 2023 Feb 6;220(2):e20220906. doi: 10.1084/jem.20220906. Epub 2022 Nov 15. PubMed |
| Comprehensive Comparison of Baculoviral and Plasmid Gene Delivery in Mammalian Cells. Toth M, Reithofer M, Dutra G, Pereira Aguilar P, Durauer A, Grabherr R. Viruses. 2024 Mar 10;16(3):426. doi: 10.3390/v16030426. PubMed |
| A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response. Kim W, Song ES, Lee SH, Yang SH, Cho J, Kim SJ. Sci Rep. 2024 Mar 29;14(1):7516. doi: 10.1038/s41598-024-58315-0. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.